MENOK: Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study
Study Details
Study Description
Brief Summary
Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Near viewing duration [12 months]
Duration during near tasks
- Near viewing distance [12 months]
Distance during near tasks
- Outdoor time [12 months]
Ambient illumination to determine time spent outdoors
Secondary Outcome Measures
- Objective cycloplegic central refraction [12 months]
Change in objective refraction to measure myopia progression
- Axial length [12 months]
Change in axial length to measure myopia progression
- Subjective cycloplegic central refraction [12 months]
Change in subjective refraction to measure myopia progression
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Aged 6 to below 14 years old
-
Spherical equivalent myopic refractive error greater than -0.50 D
-
Best corrected logMAR visual acuity of 0.1 or better in each eye
-
Good ocular and general health that would not preclude them from myopia control
-
Competent enough in English to fully understand the participant information and consent form
-
Willing to undergo treatment to slow myopia progression for one year
Exclusion Criteria:
-
Strabismus at distance or near, amblyopia or significant anisometropia (>1.50 D)
-
Systemic or ocular conditions that may affect contact lens use (e.g. severe allergy) or refractive development (e.g. ptosis)
-
Previous history of ocular surgery, trauma or chronic ocular disease that may affect their vision
-
Ocular or systemic medication use which may interfere or interact with myopia treatment or ocular development
-
Child, parents or guardians not willing to comply with treatment and/or follow-up schedule and planning to migrate or move during the one-year study duration
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | School of Optometry, University of California, Berkeley | Berkeley | California | United States | 94720 |
2 | New England College of Optometry | Boston | Massachusetts | United States | 02115 |
3 | State University of New York (SUNY), College of Optometry | New York | New York | United States | 10036 |
4 | School of Optometry and Vision Science, UNSW | Sydney | New South Wales | Australia | 2052 |
5 | Optometry and Vision Science, Queensland University of Technology | Kelvin Grove | Queensland | Australia | 4059 |
Sponsors and Collaborators
- The University of New South Wales
- Queensland University of Technology
- New England College of Optometry
- State University of New York College of Optometry
- University of California, Berkeley
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MENOK